Clinical Trial Update: Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the inflammation-targeting drug salsalate in type 1 diabetes with peripheral neuropathy has completed and posted results as of 2025-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Salsalate (Salsalate)

Snippet

Sponsor: University of Michigan | Conditions: Type 1 Diabetes, Peripheral Neuropathy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-05-16